Update 4: FDA Wants More Safety Data on Merck Drug The Food and Drug Administration told Merck  amp; Co. that it requires further safety and efficacy data before it will approve its successor drug to now defunct pain reliever Vioxx, the pharmaceutical maker announced Friday.